GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » Other Gross PPE

Autolus Therapeutics (Autolus Therapeutics) Other Gross PPE : $114.54 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics Other Gross PPE?

Autolus Therapeutics's Other Gross PPE for the quarter that ended in Mar. 2024 was $114.54 Mil.

Autolus Therapeutics's quarterly Other Gross PPE increased from Sep. 2023 ($98.42 Mil) to Dec. 2023 ($105.75 Mil) and increased from Dec. 2023 ($105.75 Mil) to Mar. 2024 ($114.54 Mil).

Autolus Therapeutics's annual Other Gross PPE declined from Dec. 2021 ($67.77 Mil) to Dec. 2022 ($66.09 Mil) but then increased from Dec. 2022 ($66.09 Mil) to Dec. 2023 ($105.75 Mil).


Autolus Therapeutics Other Gross PPE Historical Data

The historical data trend for Autolus Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics Other Gross PPE Chart

Autolus Therapeutics Annual Data
Trend Sep16 Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial 51.94 85.76 67.77 66.09 105.75

Autolus Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 65.87 95.37 98.42 105.75 114.54

Autolus Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Autolus Therapeutics (Autolus Therapeutics) Business Description

Traded in Other Exchanges
Address
191 Wood Lane, The MediaWorks, London, GBR, W12 7FP
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Autolus Therapeutics (Autolus Therapeutics) Headlines

From GuruFocus

Autolus Announces Pricing of Public Offering

By Value_Insider Value_Insider 12-09-2022

Autolus Therapeutics announces Board changes

By Stock market mentor Stock market mentor 01-20-2023